Uncommon Therapeutics
ActiveA Disease Focused Biotech, Building Multiple Billion Dollar Drugs
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Founders · 2
Serial Entrepreneur Building Therapies and New Biz Models for Rare Disease
Biotech entrepreneur and biomedical scientist specializing in modeling neurological disorders using stem cells, in vivo models, and computational biology to drive breakthroughs in neurological diseases
Launch
Developing multiple high‐value ($b) therapeutics per disease, combining new tools and deep expertise to deliver cures
Uncommon designs and develops disease-focused therapeutics using a polytherapy strategy for Rett Syndrome and other rare diseases, leveraging AI-enabled drug discovery and tech-inspired approaches. They announce three novel therapeutics targeting the disease’s underlying cause, shown to work in patient cells, and aim to build a platform to deliver therapies that could improve quality of life and potentially deliver cures.
Related startups
AI drug discovery platform for neurotherapeutics
Enabling Tissue Targeting of Therapies
